Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
uniQure N.V. (QURE) Class Action Lawsuit: Investors Face April 13, 2026, Deadline
Kessler Topaz Meltzer & Check, LLP has filed a securities fraud class action lawsuit against uniQure N.V. (QURE) on behalf of investors who bought shares between September 24, 2025, and October 31, 2025. The lawsuit alleges that uniQure made misleading statements and omissions regarding its Huntington’s disease gene therapy drug, AMT-130, and its FDA approval process. Investors who suffered losses and purchased shares during the specified Class Period have until April 13, 2026, to seek lead plaintiff status.